Frontiers of Science seminar: Dr. Aviv Regev

Aika

29.4.2021 klo 18.00 - 19.00
Frontiers of Science

April 29th at 18:00
online event

Dr. Aviv Regev, Genentech Inc., US
"Cell Atlases as roadmaps to treat disease"
host: Riitta Lahesmaa (riitta.lahesmaa@utu.fi)

Registration latest at April 28th at 12:00
https://link.webropolsurveys.com/S/757F3676A3638A22

Students and early-career postdocs are welcome to share a virtual cup of coffee and discuss with Prof. Regev after the seminar. This is a great possibility to learn hosting skills in friendly environment and create connections for future. Every student are welcome to join, in spite of which research group they belong to.
If you got interested, after registering to the event please send an email to biocityturku@bioscience.fi


As executive Vice President, Genentech Research and Early Development (gRED), Aviv Regev is responsible for the management of all aspects of Genentech’s drug discovery and drug development activities. She is a member of the Genentech utive Committee and the expanded Corporate utive Committee for Roche.

Prior to Genentech, Regev served as Chair of the Faculty, Core Institute Member, founding director of the Klarman Cell Observatory, and member of the utive Leadership Team of the Broad Institute of MIT and Harvard, as well as Professor of Biology at MIT and Investigator at the Howard Hughes Medical Institute. She is a founding co-chair of the Human Cell Atlas.

Regev is a leader in deciphering molecular circuits that govern cells, tissues and organs in health and their malfunction in disease. Her lab has pioneered foundational experimental and computational methods in single-cell genomics, working toward greater understanding of the function of cells and tissues in health and disease, including autoimmune disease, inflammation and cancer. She is a member of the National Academy of Sciences and National Academy of Medicine, and she is also a Fellow of the International Society of Computational Biology.

Regev has served on multiple corporate advisory, scientific advisory, and journal editorial boards, including the advisory committee to the National Human Genome Research Institute at the National Institutes of Health. Regev has a Ph.D. in computational biology and a Master of Science from Tel Aviv University.


Selected publications

Rozenblatt-Rosen O, Shin JW, Rood JE, Hupalowska A; Human Cell Atlas Standards and Technology Working Group, Regev A, Heyn H. 2021. Building a high-quality Human Cell Atlas. Nat Biotechnol. Online ahead of print.

Jerby-Arnon L, Neftel C, Shore ME, Weisman HR, Mathewson ND, McBride MJ, … , Rozenblatt-Rosen O, Suvà ML, Riggi N, Regev A. 2021. Opposing immune and genetic mechanisms shape oncogenic programs in synovial sarcoma. Nat Med. Online ahead of print.

Kinker GS, Greenwald AC, Tal R, Orlova Z, Cuoco MS, McFarland JM, Warren A, … , Regev A, Tirosh I. 2020. Pan-cancer single-cell RNA-seq identifies recurring programs of cellular heterogeneity. Nat Genet. 52:1208-1218

Drokhlyansky E, Smillie CS, Van Wittenberghe N, Ericsson M, Griffin GK, Eraslan G, Dionne D, Cuoco MS, Goder-Reiser MN, Sharova T, Kuksenko O, Aguirre AJ, Boland GM, Graham D, Rozenblatt-Rosen O, Xavier RJ, Regev A. 2020. The Human and Mouse Enteric Nervous System at Single-Cell Resolution. 182:1606-1622

Li B, Gould J, Yang Y, Sarkizova S, Tabaka M, Ashenberg O, Rosen Y, Slyper M, Kowalczyk MS, Villani AC, Tickle T, Hacohen N, Rozenblatt-Rosen O, Regev A. 2020. Cumulus provides cloud-based data analysis for large-scale single-cell and single-nucleus RNA-seq. Nat Methods. 17:793-798

Izar B, Tirosh I, Stover EH, Wakiro I, Cuoco MS, Alter I, Rodman C, … , Rotem A, Regev A. 2020. A single-cell landscape of high-grade serous ovarian cancer. Nat Med. 26:1271-1279